The rising geopolitical tensions highlight the vulnerabilities in global supply chains for essential medicines, particularly antibiotics, which are predominantly produced in Asia. Europe, now reliant on these imports, faces significant risks to its healthcare and defense capabilities. The Critical Medicines Act, proposed in May 2023, aims to address these vulnerabilities by enhancing domestic production and ensuring the security of supply. It is crucial for the EU to integrate this act into its broader security framework to prevent potential crises stemming from medicine shortages. Teljes cikk (Euronews.com)